经公司自查，并书面征询控股股东及实际控制人，截至本公告披露日，公司及控股股东、实际控制人均 不存在影响公司股票交易异常波动的重大事项，不存在应披露而未披露的重大信息。 洛阳钼业（603993）(03993)公布，公司A股股票于2025年9月29日、9月30日及10月9日连续3个交易日内 收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动。 ...

香港联交所最新资料显示，9月25日，摩根大通增持洛阳钼业（603993）(03993)1106.7433万股，每股均 价13.9622港元，总金额约为1.55亿港元。增持后最新持股数目约为2.39亿股，最新持股比例为6.06%。 ...

据天眼查APP显示，洛阳栾川钼业集团股份有限公司成立于1999年12月22日，注册资本427886.20352万 人民币。（数据宝） 9月26日洛阳钼业大宗交易一览 | 成交量 | 成交金额 | 成交价格 | 相对当日收盘折 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | | （万股） | （万元） | （元） | 溢价（%） | | | | 30.00 | 414.00 | 13.80 | 0.00 | 国泰海通证券股份 | 华泰证券股份有限公司上海 | | | | | | 有限公司总部 | 武定路证券营业部 | （文章来源：证券时报网） 洛阳钼业9月26日大宗交易平台出现一笔成交，成交量30.00万股，成交金额414.00万元，大宗交易成交 价为13.80元。该笔交易的买方营业部为国泰海通证券股份有限公司总部，卖方营业部为华泰证券股份 有限公司上海武定路证券营业部。 进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为1.57亿元。 证券时报·数据宝统计显示，洛阳钼业今日收盘价为13.80元，下跌0.50%，日换手率为2.26%，成 ...

据天眼查APP显示，洛阳栾川钼业集团股份有限公司成立于1999年12月22日。注册资本427886.20352万 人民币。（数据宝）注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （原标题：洛阳钼业成交额创2022年6月23日以来新高） 数据宝统计，截至11:00，洛阳钼业成交额68.53亿元，创2022年6月23日以来新高。最新股价上涨 9.98%，换手率2.85%。上一交易日该股全天成交额为18.63亿元。 ...

Group 1 - The core viewpoint of the news is that Jinmoly Co., Ltd. experienced a significant stock decline of 5.03% on September 16, with a trading price of 14.91 yuan per share and a total market capitalization of 48.109 billion yuan [1] - Jinmoly Co., Ltd. is primarily engaged in molybdenum mining, production, and sales of molybdenum-related products, with 90.14% of its revenue coming from molybdenum mining and processing [1] - The company was established on May 16, 2007, and went public on April 17, 2008, located in Xi'an, Shaanxi Province [1] Group 2 - Western Lide Fund holds a significant position in Jinmoly Co., Ltd., with its fund, Western Lide CSI 500 Index Enhanced A (502000), owning 1.2% of its net value in shares [2] - The fund has reported a floating loss of approximately 1.5475 million yuan due to the recent stock decline [2] - The fund has a total scale of 1.4 billion yuan and has achieved a year-to-date return of 22.86% [2] Group 3 - The fund manager of Western Lide CSI 500 Index Enhanced A is Sheng Fengyan, who has been in the position for nearly 9 years [3] - During his tenure, the fund has achieved a maximum return of 184.65% and a minimum return of -24.88% [3]

Core Viewpoint - The non-ferrous metal sector is experiencing a surge, driven by expectations of a Federal Reserve interest rate cut and improving demand, particularly in the rare earth and industrial metals markets [3][4]. Group 1: ETF Performance - The non-ferrous metal leader ETF (159876) saw a price increase of over 1.8% as of September 3, with a trading volume exceeding 12 million yuan within the first 15 minutes of opening [1]. - The ETF attracted significant inflows of 75.6 million yuan over the past two days, reaching a new high of 207 million yuan in total assets as of September 2 [1]. - Key constituent stocks included silver, which hit the daily limit, while Western Gold and Zhongjin Gold rose by 5.81% and 4.79%, respectively [1]. Group 2: Market Trends - The industrial metals sector is benefiting from rising copper prices due to supply constraints, with a projected decrease of 52,500 tons in electrolytic copper production in September [3]. - The lithium market is facing oversupply, but high-cost production is being phased out, which may lead to price recovery [3]. - The overall sentiment in the non-ferrous metals market remains strong, supported by macroeconomic factors and supply disruptions [3]. Group 3: Strategic Insights - The non-ferrous metals sector is positioned for upward price movement due to low valuations and improving market conditions, with a potential "bull market" beginning [3][4]. - The strategic importance of metals like rare earths and lithium is highlighted in the context of global competition and domestic policy shifts aimed at optimizing production factors [4]. - The non-ferrous metal leader ETF provides diversified exposure to various metals, including copper (25.3%), aluminum (14.2%), and rare earths (13.8%), which helps mitigate investment risks [4].

Market Overview - On September 1, A-shares saw all three major indices rise, marking a positive start to September. The Shanghai Composite Index increased by 0.46%, the Shenzhen Component Index rose by 1.05%, and the ChiNext Index gained 2.29%, with over 3,200 stocks in the market rising [1] - The main broad-based indices included the STAR 100, which rose by 2.34%, leading the gains [1] Sector Performance - In the sector performance, the telecommunications sector led with a rise of 5.22%, followed by the comprehensive sector at 4.27%, and non-ferrous metals at 3.46%. Conversely, non-bank financials fell by 1.28%, banks by 1.03%, and household appliances by 0.54% [7] Key Highlights in Biotechnology - The innovative drug sector experienced significant gains, with several companies reporting strong mid-year results. Notably, Jingtai Holdings reported a 403.8% year-on-year revenue increase for H1, driven by drug discovery collaborations and substantial orders from top global pharmaceutical companies [7] - Junshi Biosciences saw an 18% increase in R&D investment year-on-year, with core product sales exceeding 800 million yuan and a $350 million dual-antibody licensing agreement with a multinational pharmaceutical company [7] - Pfizer plans to invest $13 billion in business development focused on oncology, with its Chief Strategy Officer visiting China to explore collaboration opportunities [7] Investment Insights - Pacific Securities suggests focusing on the pharmaceutical sector due to the impact of market pricing power and funding changes, particularly in AI healthcare and innovative drugs. The report emphasizes that the liquidity and risk appetite are expected to enhance the visibility of biotech catalysts [8] - In the non-ferrous metals sector, Goldman Sachs' research indicates investor optimism regarding China's 2025 GDP growth target, with an upward adjustment in short-term export expectations. This has led to increased attention on cyclical sectors like non-ferrous metals [8] - The report from Minmetals Securities highlights that the non-ferrous metals industry has reached a cost-cutting bottleneck, necessitating attention to corporate decision-making impacts on lithium supply and costs [8] Related Products - The report mentions various ETFs related to the non-ferrous metals sector, including ETF 159880 and its corresponding off-market links [9]

Group 1 - The stock price of Jinchuan Group Co., Ltd. (SH:601958) reached the daily limit, closing at 16.50 yuan, with an increase of 10.00% [1] - The total market capitalization of the company is 53.239 billion yuan [1]

Group 1 - The core viewpoint of the article highlights the poor financial performance of Yongshan Lithium Industry in the first half of 2025, with a significant revenue drop of 28.6% to 2.392 billion yuan and a net loss attributable to shareholders of 144 million yuan, a year-on-year decline of 315.6% [1] - The company's main business segments, lithium salt products and molybdenum products, both underperformed, negatively impacting overall performance. The lithium salt business generated revenue of 617 million yuan, down 19.95% year-on-year, while the molybdenum business earned 1.774 billion yuan, also showing a decline [1] - From 2022 to the first half of 2025, the company reported revenues of 7.061 billion yuan, 7.505 billion yuan, 5.895 billion yuan, and 2.392 billion yuan, with respective changes of 81.58%, 6.29%, -21.45%, and -28.63% [1] Group 2 - The overall lithium carbonate market exhibited a volatile pattern in the first half of 2025, initially rising due to inventory digestion and seasonal demand expectations, but later stabilizing at lower levels [1] - The company's profitability has also declined, with the sales gross margin dropping from 8.89% in the first half of 2023 to 1.58% in the first half of 2025, and the net profit margin turning negative [1] - The operational efficiency of the company has worsened, with a significant decrease in inventory turnover rate and total asset turnover rate [2]

Core Insights - Yongshan Lithium Industry reported a significant decline in revenue and net profit for the first half of 2025, with revenue dropping by 28.6% to 2.392 billion yuan and a net loss of 144 million yuan, a year-on-year decrease of 315.6% [1][3] - The company's two main business segments, molybdenum and lithium, both underperformed due to price pressures, negatively impacting overall performance [1][3] Revenue Performance - The lithium salt business revenue decreased by 19.95% to 617 million yuan, while the molybdenum business revenue fell by 31.23% to 1.774 billion yuan [3] - Revenue figures for the years 2022 to 2025 show a trend of fluctuating performance: 7.061 billion yuan in 2022, 7.505 billion yuan in 2023, 5.895 billion yuan in 2024, and 2.392 billion yuan in the first half of 2025, with respective year-on-year changes of 81.58%, 6.29%, -21.45%, and -28.63% [1] Profitability Analysis - The company's net profit figures indicate a troubling trend: 492 million yuan in 2022, a loss of 337 million yuan in 2023, a profit of 25.42 million yuan in 2024, and a loss of 144 million yuan in the first half of 2025, with year-on-year changes of 2605.67%, -168.52%, 107.54%, and -315.62% [1] - The gross profit margin has been declining, dropping from 8.89% in the first half of 2023 to 1.58% in the first half of 2025, while the net profit margin turned negative, falling from 1.99% in the first half of 2024 to -6.02% in the first half of 2025 [3] Operational Efficiency - The company's inventory turnover rate has significantly decreased, indicating reduced operational efficiency [5] - In the first half of 2025, Yongshan Lithium's inventory turnover rate was 4.34, with inventory turnover days extending to 41.47 days, reflecting a decline in turnover efficiency [7]